Recorded: 23 Feb 2012
Oh, it's a fantastic role. I mean, we-- just to give you an example, we're now working with a lab here at Scripps that is headed by John Yates to do a comprehensive study of the proteome, all the proteins and cells, and the changes that are induced in the levels of these proteins by individual oncogenes. And the only way you can do this is by having the entire human genome sequenced. That enables the people who work on mospeck to generate the kind of programs and the kind of software that allows the analysis of the entire human proteome.
Dr. Peter Vogt, M.D., Ph.D., serves as Member of Scientific Advisory Board of Onconova Therapeutics, Inc. Dr. Vogt is at the Scripps Institute in La Jolla, CA. He is a member of the National Academy of Sciences and a Lasker Award winner. His fundamental studies on oncogenic avian retroviruses led to the identification of oncogenes in human cells. Dr. Vogt is the editor-in-chief of Virology, a scientific journal.
Dr. Peter Vogt intends to continue his work at the Scripps Research Institute. He is currently working to generate small molecule inhibitors that interfere with the spread of cancer as a new therapeutic approach.